Answers are grounded in this paper and cite their sources.
A 64-year-old woman with rheumatoid arthritis (RA) began to complain of recurrent non-productive cough 5 months after starting adalimumab. The chest radiograph and high-resolution computed tomographic findings revealed diffuse ground-glass attenuation. Her clinical course suggested that interstitial pneumonia (IP) may have been induced by adalimumab, and she was successfully treated with a medium dose of corticosteroid. This case indicates that adalimumab-associated IP should be considered if a RA patient develops non-productive cough following adalimumab therapy.
No takes yet. Share an insight, caveat, or question.
Yamazaki et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: